跳至主要内容
临床试验/EUCTR2013-004228-12-AT
EUCTR2013-004228-12-AT进行中(未招募)不适用

Enhanced efficacy of photodynamic therapy in combination with 3,75% imiquimod - a randomised, prospective , observer-blinded study in patients with actinic keratosis - PDT vs PDT and 3,75% Imiquimod in patients with AK

Medizinische Universität Wien, univ. Klinik f. Dermatologie0 个研究点开始时间: 2014年9月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with clinically confirmed actinic keratosis in the face and scalp
  • Age 18 years or older
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 36

排除标准

  • Known allergy to imiquimod and aminlevulinic acid
  • Patients with porphyria or taking photosensitizing drugs
  • Patients with severe compromised general state
  • Patients who are participating in another study
  • Patients unable to stick to the study protocol
  • Pregnant or lactating women

研究者

发起方
Medizinische Universität Wien, univ. Klinik f. Dermatologie

相似试验